Finally, expression of xenobiotic metabolising enzymes with actual basic metabolic capacity in breast tumours has been identified as a potentially important factor in the modulation of the, so far underestimated, intratumoral CYP-mediated prodrug activation. This evidence concerns the gene PPIG and breast neoplasm.